N
RVLP

Nuveen’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

Nuveen’s Portfolio RVLP Stock Details RVLP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-87,228
Closed -$285K – 3583
2021
Q1 		$285K Buy
87,228
+19,213
+28% +$79K ﹤0.01% 3182
2020
Q4 		$281K Hold
68,015
– – ﹤0.01% 3145
2020
Q3 		$368K Buy
68,015
+45,115
+197% +$260K ﹤0.01% 3034
2020
Q2 		$154K Buy
+22,900
New +$112K ﹤0.01% 3131

Other funds holding RVLP

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
RA
Rovida Advisors Fort Lauderdale, Florida $116M AUM 12.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Nuveen's RVLP Position: Q2 2021 in Review

Nuveen sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q2 2021, closing a stake of 87,228 shares — an estimated $285K sold.

Nuveen first reported a position in RVLP in Q2 2020 and held it in 4 quarters. The position peaked at $368K in Q3 2020. 46 funds tracked by Wall St. Rank hold RVLP as of Q2 2021.

  • Nuveen reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q2 2021 after selling out during the quarter.
  • Nuveen sold 87,228 RVL Pharmaceuticals plc Ordinary Shares shares in Q2 2021, an estimated $285K.
  • Nuveen first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q2 2020 and held it in 4 quarters.
  • Nuveen's RVL Pharmaceuticals plc Ordinary Shares position peaked at $368K in Q3 2020.
  • 46 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q2 2021.

Based on Nuveen's 13F filing for Q2 2021, filed 16 Aug 2021.